Abstract
The synthesis of Bsmoc-N-methyl amino acids is presented. The first step involves p-toluenesulfonic acid (TsOH) catalysed condensation of a Bsmoc-amino acid with paraformaldehyde to furnish N-Bsmoc-5-oxazolidinone under MW irradiation. This intermediate is reduced to the corresponding N-methyl amino acid using triethylsilane (Et3SiH) and trifluoroacetic acid (TFA) at r.t. The N-methyl amino acids are converted into corresponding acid fluorides using diethylaminosulfur trifluoride (DAST) and employed as coupling agents in the synthesis of dipeptides. The peptide coupling was mediated by KOAt in CH2Cl2.
Keywords: Bsmoc N methyl amino acids, 5-Oxazolidinone, Amino acid fluorides, KOAt
Protein & Peptide Letters
Title: Synthesis of 1,1-Dioxobenzo[b]thiophene-2-ylmethyloxycarbonyl (Bsmoc) Protected N-Methyl Amino Acids by Reduction of Bsmoc-5-Oxazolidinones and Their Use in Peptide Synthesis
Volume: 16 Issue: 2
Author(s): Chennakrishnareddy Gundala, Subramanyam J. Tantry, Shankar A. Naik and Vommina Venkata Sureshbabu
Affiliation:
Keywords: Bsmoc N methyl amino acids, 5-Oxazolidinone, Amino acid fluorides, KOAt
Abstract: The synthesis of Bsmoc-N-methyl amino acids is presented. The first step involves p-toluenesulfonic acid (TsOH) catalysed condensation of a Bsmoc-amino acid with paraformaldehyde to furnish N-Bsmoc-5-oxazolidinone under MW irradiation. This intermediate is reduced to the corresponding N-methyl amino acid using triethylsilane (Et3SiH) and trifluoroacetic acid (TFA) at r.t. The N-methyl amino acids are converted into corresponding acid fluorides using diethylaminosulfur trifluoride (DAST) and employed as coupling agents in the synthesis of dipeptides. The peptide coupling was mediated by KOAt in CH2Cl2.
Export Options
About this article
Cite this article as:
Gundala Chennakrishnareddy, Tantry J. Subramanyam, Naik A. Shankar and Sureshbabu Venkata Vommina, Synthesis of 1,1-Dioxobenzo[b]thiophene-2-ylmethyloxycarbonyl (Bsmoc) Protected N-Methyl Amino Acids by Reduction of Bsmoc-5-Oxazolidinones and Their Use in Peptide Synthesis, Protein & Peptide Letters 2009; 16 (2) . https://dx.doi.org/10.2174/092986609787316270
DOI https://dx.doi.org/10.2174/092986609787316270 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Antibacterial Properties of Oxazolidinones and Oxazinanones
Anti-Infective Agents in Medicinal Chemistry Immunonutrition in Surgical Patients
Current Drug Targets Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns
Current Genomics Vitamin D and its Possible Relationship to Neuroprotection in COVID-19: Evidence in the Literature
Current Topics in Medicinal Chemistry Natural Products Against COVID-19 Inflammation: A Mini-Review
Combinatorial Chemistry & High Throughput Screening A Deep Learning Model for Diagnosing COVID-19 and Pneumonia through X-ray
Current Medical Imaging An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology
Endocrine, Metabolic & Immune Disorders - Drug Targets Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
Current Topics in Medicinal Chemistry Insight View on Possible Role of Fluoroquinolones in Cancer Therapy
Current Topics in Medicinal Chemistry Sirtuin Modulators: Targets for Metabolic Diseases and Beyond
Current Topics in Medicinal Chemistry New Developments and Applications of Docking and High-Throughput Docking for Drug Design and in silico Screening
Current Computer-Aided Drug Design AMPA Receptor Antagonists
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery The Impact of the Coronavirus (COVID-19) Infection on the Drug- Metabolizing Enzymes Cytochrome P450s
Drug Metabolism and Bioanalysis Letters Synthesis, Screening and in silico Simulations of Anti-Parasitic Propamidine/Benzimidazole Derivatives
Medicinal Chemistry Synthesis and Biological Activity of Some Nucleoside Analogs of 3-Cyanopyridin-2- one
Current Organic Synthesis Anti-Cancer Activity of 2,4-Disubstituted Thiophene Derivatives: Dual Inhibitors of Lipoxygenase and Cyclooxygenase
Medicinal Chemistry Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins
Current Topics in Medicinal Chemistry Microbes, Immunity and Multiple Sclerosis
Current Immunology Reviews (Discontinued) Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis (Black Fungus), during the Era of Coronavirus Disease-2019 (COVID-19): An Overview
Current Diabetes Reviews